REFERENCES
- Von Orelli J., Leuenberger H. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution. Int. J. Pharm. 2004; 287: 135–145
- Alderborn G., Pasanen K., Nystroem C. Studies on direct compression of tablets. XI. Characterization of particle fragmentation during compaction by permeametry measurement of tablets. Int. J. Pharm. 1985; 23: 79–86
- Armstrong N.A., Palfrey L.P. The effect of machine speed on the consolidation of four directly compressible tablet diluents. J. Pharm. Pharmacol. 1989; 41: 149–151
- Leuenberger H., Rohera B.D., Hass Ch. Percolation theory—A novel approach to solid dosage form design. Int. J. Pharm. 1987; 38: 109–115
- Roberts R.J., Rowe R.C. Brittle/ductile behaviour in pharmaceutical materials used in tabletting. Int. J. Pharm. 1987; 36: 205–209
- Roberts R.J., Rowe R.C. The effect of punch velocity on the compaction of a variety of materials. J. Pharm. Pharmacol. 1985; 37: 377–384
- Amidon G.L., Lennernaes H., Shah V.P., Crison J.R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995; 12(3)413–420
- 8. FDA/CDER. Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system. Guidance for Industry, August 2000.
- Tokumura T. A screening system of solubility for drug design and discovery. Pharm Tech Japan 2000; 16(13)19–27
- Yazdanian M., Briggs K., Jankovsky C., Hawi A. The “high solubility” definition of the current FDA guidance on biopharmaceutical classification system may be too strict for acidic drugs. Pharm. Res. 2004; 21(2)293–299
- Dussert A., Chulia D., Jeannin C., Ozil P. Parametric study of fluidized-bed granulation of a low density micronized powder. Drug Dev. Ind. Pharm. 1995; 21(12)1439–1452
- Adam A., Schrimpl L., Schmidt P.C. Factors influencing capping and cracking of mefenamic acid tablets. Drug Dev. Ind. Pharm. 2000; 26(5)489–497
- Brunauer S., Emmett P.H., Teller E. Adsorption of gases in multimolecular layers. J. Am. Chem. Soc. 1938; 60: 309–319
- Sunada H., Hasegawa M., Makino T., Sakamoto H., Fujita K., Tanino T., Kokubo H., Kawaguchi T. Study of standard tablet formulation based on fluidized-bed granulation. Drug Dev. Ind. Pharm. 1998; 24(3)225–233
- www.mcc-online.com/presster.htm, Metropolitan Computing Corporation
- 16. Micromeritics Corporate. PoreSizer 9320 Operator's Manual, March 2001, Appendix J: Automatic data reduction.
- Juppo A.M., Yliruusi J. Effect of amount of granulation liquid on total pore volume and pore size distribution of lactose, glucose and mannitol granules. Eur. J. Pharm. Biopharm. 1994; 40(5)299–309
- Fell J.T., Newton J.M. The tensile strength of lactose tablets. J. Pharm. Pharmacol. 1968; 20: 657–658
- Dees P.J., Polderman J. Mercury porosimetry in pharmaceutical technology. Powder Technol. 1981; 29: 187–197
- Leuenberger H. The compressibility and compactibility of powder systems. Int. J. Pharm. 1982; 12: 41–55
- Adam A., Schrimpl L., Schmidt P.C. Some physicochemical properties of mefenamic acid. Drug Dev. Ind. Pharm. 2000; 26(5)477–487
- Wikberg M., Alderborn G. Compression characteristics of granulated materials. IV. The effect of granule porosity on the fragmentation propensity and the compactibility of some granulations. Int. J. Pharm. 1991; 69: 239–253
- Zuurman K., Bolhuis G.K., Vromans H. Effect of binder on the relationship between bulk density and compactibility of lactose granulations. Int. J. Pharm. 1995; 119: 65–69
- Luginbuehl R., Leuenberger H. Use of percolation theory to interpret water uptake, disintegration time and intrinsic dissolution rate of tablets consisting of binary mixtures. Pharm. Acta Helv. 1994; 69: 127–134